Penicillin class antibiotics have demonstrated varying degrees of in vivo and in vitro success when tested against Chlamydia trachomatis. The activity of ampicillin-sulbactam, an agent commonly utilized in the treatment of pelvic infections, was tested to ascertain if any antichlamydial activity is present. Up to six endocervical isolates of C. trachomatis were tested against each of five antibiotics including doxycycline, erythromycin, clindamycin, ampicillin/sulbactam, and sulbactam alone. McCoy cell monolayers were inoculated with high inclusion counts of 10,000-30,000 inclusion-forming units (IFU) per coverslip, and exposed to each antibiotic. Up to nine subsequent antibiotic free culture passes were performed to assess the viability of abnormal inclusions. Doxycycline, erythromycin, and clindamycin achieved 100% eradication of inclusions at concentrations of 4.0, 2.0, and 1.0 g/mL. Exposure to ampicillin/sulbactam resulted in a greater than 99% reduction in the inclusion count at 32.0 g/mL, while sulbactam by itself demonstrated considerably less activity. Abnormal inclusions were noted only in the ampicillin/sulbactam exposed cells, and these, plus all inclusions remaining following sublethal exposure to the other antibiotics, resulted in regrowth to control levels in subsequent passes. Doxycycline and erythromycin demonstrated excellent activity. Clindamycin and ampicillin/sulbactam also significantly reduced inclusion formation, and therefore may provide adequate C. trachomatis coverage in patients receiving these antibiotics for pelvic infections.
lent sexually transmitted organisms of the female genital tract. Infection may result in serious sequelae such as infertility, ectopic pregnancy, and pelvic inflammatory disease. Treatment regimens usually consist of tetracycline or erythromycin; however, sulfa drugs and clindamycin have demonstrated good activity, z '3 Penicillin-based antibiotics have demonstrated efficacy in some in vitro studies, 4'5 and in fact have recently been recommended as an alternative therapy to erythromycin in the treatment of chlamydial infection in pregnancy. 6 However, due to the elongated life cycle of C. trachomatis, single dose therapy with penicillin G, tetracycline, or erythromycin does not cure cases of urethritis caused by C.
trachomatis. 6 Penicillins have also been noted to produce abnormal inclusions, which may revert to normal at a later time. 7 This observation may have possibly discouraged the study of newer broad spectrum penicillins for treatment of C. trachomat# infections despite early, although limited, clinical success. Penicillins have been reported to eradicate C. trachomatis in eight of ten women treated with a 21-day course of ampicillin for cervical and/or urethral infection. 8 Normal inclusions were noted following antibiotic exposure to sulbactam, clindamycin, doxycycline, and erythromycin as well as the control groups, and were regular in shape and stained uniformly in brilliant green (Fig. 1) . Abnormal inclusions were smaller, misshaped, appeared hollow, and stained faintly (Fig. 2 
